The life sciences industry is a significant part of our firm's practice. WilmerHale has represented life sciences clients in boardrooms and courtrooms across the United States and Europe for four decades. As a result, we understand the business of our life sciences clients and the regulatory, competitive and consumer demands that the industry is currently confronting.
We represent public and private companies, investment banks and venture capitalists in all aspects of the life sciences industry, including:
- Corporate finance
- Licensing and alliances
- Mergers and acquisitions
- Patent prosecution and other intellectual property matters
- Patent, product liability, securities and other litigation
- FDA, competition and other regulatory matters
- Real estate
More than 100 of our lawyers devote a significant portion of their practice to these industries. Many of these lawyers have advanced degrees in relevant scientific disciplines. Some of our previous experience can be viewed here.
As a result of our skill and experience in the life sciences field, we have received many accolades, including:
- Chambers Global 2013 recognized WilmerHale as a leader in life sciences with an "outstanding US practice coupled with international reach."
- PLC Life Sciences Industry Super League 2012 named WilmerHale among the top ten law firms for having "a strong transatlantic life sciences practice."
- PLC Cross-border Life Sciences Handbook 2011/12, 2009/10, 2008/09, 2007/08 and 2006/07 named WilmerHale a leading law firm in the area of life sciences.
- Chambers USA 2013, 2012, 2011, 2010, 2009, 2008 and 2007 recognized our nationwide practice as a leader in life sciences.
- In January 2012, The American Lawyer recognized WilmerHale as Intellectual Property Litigation Department of the Year Finalist.
The life sciences industry is a significant part of our firm's practice. WilmerHale has represented life sciences clients in boardrooms and courtrooms across the United States and Europe for four decades. As a result, we understand the business of our life sciences clients and the regulatory, competitive and consumer demands that the industry is currently confronting.
We represent public and private companies, investment banks and venture capitalists in all aspects of the life sciences industry, including:
Read More